Unique ID issued by UMIN | UMIN000003044 |
---|---|
Receipt number | R000002844 |
Scientific Title | Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance - Impact on liver function and virological response to Pegylated Interferon alpha-2b/Ribavirin- |
Date of disclosure of the study information | 2010/01/15 |
Last modified on | 2015/01/15 10:47:05 |
Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance - Impact on liver function and virological response to Pegylated Interferon alpha-2b/Ribavirin-
Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance (EPOCH)
Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance - Impact on liver function and virological response to Pegylated Interferon alpha-2b/Ribavirin-
Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance (EPOCH)
Japan |
Chronic hepatitis C
Hepato-biliary-pancreatic medicine |
Others
NO
The aim of this study is to elucidate whether improvement of insulin resistance through diet and exercise intervention influenced liver function and virological response to pegylated interferon / ribavirin in chronic hepatitis C patients.
Efficacy
Exploratory
Pragmatic
Not applicable
(1) the degree of improvement in liver function
(2) the virological responce rate
(1) the degree of improvement in HOMA-IR
(2) the change of body weight and waist circumference
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Behavior,custom |
Patients undergo the following dietary and exercise intervention for more than 3 months.
Diet therapy: Nutritional education by dietitian. Record of diet diary.
Exercise therapy: Instruction based on "exercise guide 2006" publishing by Ministry of Health, Labour and Welfare in Japan. Record of exercise diary.
Not applicable |
Not applicable |
Male and Female
Patients satisfying all the below are eligible.
(1)Chronic hepatitis C
(2)HCV genotype 1b or 2 with high viral load (5.0 or >5.0 logIU/mL)
(3)Insulin resistance (HOMA-IR 2 or >2)
(1)pregnancy, its possibility or lactation
(2)hypersensitivity to IFN, pegylated IFN or ribavirin
(3)uncontrollable cardiac disease
(4)hemoglobinopathy
(5)creatinine clearance less than 50 mL/min
(6)severe mental illnesses such as depression or past history
(7)decompensated liver disease
(8)autoimmune hepatitis
(9)taking medication for DM or poor control of blood glucose levels
40
1st name | |
Middle name | |
Last name | Toshihiko Mizuta |
Saga Medical School
Department of Internal Medicine
5-1-1 Nabeshima, Saga, Japan
0952-34-2362
mizutat@cc.saga-u.ac.jp
1st name | |
Middle name | |
Last name | Yukie Watanabe |
Saga Medical School
Division of Hepatology, Diabetology & Endocrinology
5-1-1 Nabeshima, Saga, Japan
0952-34-2362
watanab2@cc.saga-u.ac.jp
Saga Medical School
Department of Iinternal Medicine, Saga Medical School
Self funding
NO
佐賀大学医学部附属病院
2010 | Year | 01 | Month | 15 | Day |
Unpublished
No longer recruiting
2007 | Year | 06 | Month | 01 | Day |
2007 | Year | 06 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 05 | Month | 01 | Day |
2011 | Year | 07 | Month | 01 | Day |
2011 | Year | 09 | Month | 01 | Day |
2010 | Year | 01 | Month | 15 | Day |
2015 | Year | 01 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002844
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |